| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD.V99.11.3962 |
| P698 | PubMed publication ID | 12010795 |
| P50 | author | Françoise Dignat-George | Q61874319 |
| P2093 | author name string | Florence Sabatier | |
| Laurence Camoin | |||
| José Sampol | |||
| Francine Anfosso | |||
| Veronique Roux | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 3962-3970 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity | |
| P478 | volume | 99 |
| Q38121367 | A glimpse of the glomerular milieu: From endothelial cell to thrombotic disease in nephrotic syndrome |
| Q31144359 | Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin |
| Q40112496 | Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro |
| Q35633008 | Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control |
| Q92853263 | Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis |
| Q36832898 | Cell-derived microparticles and exosomes in neuroinflammatory disorders |
| Q37295504 | Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? |
| Q36487783 | Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation |
| Q37004064 | Characterizing blood microparticles: technical aspects and challenges. |
| Q37744499 | Circadian clock and vascular disease |
| Q34259709 | Circulating CD62E+ microparticles and cardiovascular outcomes |
| Q35908304 | Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation |
| Q59152443 | Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes |
| Q36429640 | Circulating endothelial cells in malignant disease |
| Q37293820 | Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence |
| Q48536084 | Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome |
| Q38836585 | Circulating extracellular vesicles: Their role in tissue repair and regeneration |
| Q53292843 | Circulating procoagulant microparticles in cancer patients |
| Q26830846 | Clinical significance of procoagulant microparticles |
| Q43297937 | Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus |
| Q35934133 | Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation |
| Q26771389 | Dynamics of circulating microparticles in chronic kidney disease and transplantation: Is it really reliable marker? |
| Q37817007 | Ectosomes as immunomodulators |
| Q34024531 | Ectosomes as modulators of inflammation and immunity |
| Q48853315 | Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial mi |
| Q36270462 | Emission of membrane vesicles: roles in complement resistance, immunity and cancer |
| Q33639065 | Endothelial Extracellular Vesicles-Promises and Challenges |
| Q50171347 | Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis |
| Q64992295 | Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets. |
| Q37760426 | Endothelial activation and circulating markers of endothelial activation in kidney disease |
| Q36913515 | Endothelial aging associated with oxidative stress can be modulated by a healthy mediterranean diet |
| Q39817958 | Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases |
| Q50072140 | Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes. |
| Q36192477 | Endothelial microparticles (EMP) as vascular disease markers. |
| Q39186270 | Endothelial microparticles act as novel diagnostic and therapeutic biomarkers of circulatory hypoxia-related diseases: a literature review |
| Q36057489 | Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism |
| Q38854487 | Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases? |
| Q38001993 | Endothelial microparticles: missing link in endothelial dysfunction? |
| Q35624092 | Endothelial microparticles: sophisticated vesicles modulating vascular function |
| Q90025734 | Endothelial microvesicles carrying Src-rich cargo impair adherens junction integrity and cytoskeleton homeostasis |
| Q38908954 | Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure |
| Q39095592 | Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake |
| Q39453434 | Extracellular vesicles in renal disease |
| Q42361529 | Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants |
| Q33959551 | Fibrinolytic cross-talk: a new mechanism for plasmin formation. |
| Q33649668 | HDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production |
| Q45027017 | High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. |
| Q36783613 | How it all starts: Initiation of the clotting cascade. |
| Q37316399 | Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases |
| Q57616300 | Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome |
| Q48346587 | Influence of sex on the number of circulating endothelial microparticles and microRNA expression in middle-aged adults. |
| Q41660553 | Insights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications |
| Q60956629 | Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation? |
| Q33401969 | Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis |
| Q51732019 | Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. |
| Q36185268 | Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia |
| Q38836079 | Measurement of extracellular vesicles as biomarkers of consequences or cause complications of pathological states, and prognosis of both evolution and therapeutic safety/efficacy |
| Q37622945 | Mechanisms and markers of vascular damage in ANCA-associated vasculitis |
| Q35927423 | Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae |
| Q26783691 | Microparticles as Biomarkers of Blood Coagulation in Cancer |
| Q43171552 | Microparticles in endothelial cell and vascular homeostasis: are they really noxious? |
| Q34182691 | Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597) |
| Q46541119 | Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement |
| Q37922118 | Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis |
| Q34961040 | Microvesicles at the crossroads between infection and cardiovascular diseases |
| Q83943540 | Moderate-intensity, premeal cycling blunts postprandial increases in monocyte cell surface CD18 and CD11a and endothelial microparticles following a high-fat meal in young adults |
| Q73356977 | Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation |
| Q37541711 | Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review |
| Q47400180 | P-selectin and leukocyte microparticles are associated with venous thrombogenesis |
| Q33425214 | Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles |
| Q36759589 | Plasma microparticles and vascular disorders |
| Q38392023 | Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury. |
| Q36570485 | Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice |
| Q37071701 | Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses |
| Q24655248 | Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles |
| Q89558384 | Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases |
| Q37340172 | Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall |
| Q88922025 | Relative Deficiency of Plasma A Disintegrin and Metalloprotease with Thrombospondin Type 1 Repeats 13 Activity and Elevation of Human Neutrophil Peptides in Patients with Traumatic Brain Injury |
| Q38117725 | Revisited role of microparticles in arterial and venous thrombosis. |
| Q37138036 | Role of microparticles in atherothrombosis |
| Q37419804 | Role of selectins and fibrinolysis in VTE. |
| Q62606141 | Rôle des microparticules cellulaires à l’interface des réponses prothrombotiques et inflammatoires |
| Q35200866 | Selenium prevents microparticle-induced endothelial inflammation in patients after cardiopulmonary resuscitation |
| Q33552712 | Surface complement C3 fragments and cellular binding of microparticles in patients with SLE |
| Q92535745 | The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue Repair |
| Q28066054 | The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression |
| Q42152321 | The predictive role of circulating microparticles in patients with chronic heart failure. |
| Q38638694 | The role of microparticles in inflammation and transfusion: A concise review |
| Q40196259 | Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes |
| Q24323351 | Tissue factor and its natural inhibitor in pre-eclampsia and SGA |
| Q90657275 | Type 2 diabetes and older age contribute to elevated plasma microparticle concentrations independent of chronic stroke |
| Q33641499 | Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress |
| Q34146818 | Venous Valvular Stasis–Associated Hypoxia and Thrombosis: What Is the Link? |
| Q51075708 | Vitamin D Reduces Oxidative Stress-Induced Procaspase-3/ROCK1 Activation and MP Release by Placental Trophoblasts |
| Q51064693 | Vitamin D suppresses oxidative stress-induced microparticle release by human umbilical vein endothelial cells |
| Q80088629 | [Markers of thrombotic disease: procoagulant microparticles] |
| Q28117855 | p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia |
Search more.